Hybrid Conferencee

International Workshop on Vaccines and Biotechnology Innovation (IWVBI - 26)

3rd - 4th September 2026 | Milan, Italy

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Milan. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Milan event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Milan conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Milan, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Milan."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in mRNA Vaccine Technology

This session will explore the latest innovations in mRNA vaccine development, focusing on their design, delivery mechanisms, and efficacy. Participants will discuss the implications of mRNA technology for rapid vaccine deployment in response to emerging infectious diseases.

Track 02

Recombinant Vaccines: Strategies and Applications

This track will delve into the methodologies employed in the development of recombinant vaccines, highlighting case studies and successful applications. Discussions will include the challenges faced in the production and regulatory approval processes.

Track 03

Nanoparticle-Based Vaccine Platforms

This session will examine the role of nanoparticle technology in enhancing vaccine delivery and immune response. Researchers will present findings on the efficacy of nanoparticle-based vaccines against various pathogens.

Track 04

Viral Vector Vaccines: Innovations and Challenges

This track will focus on the use of viral vectors in vaccine development, discussing both the advantages and potential risks associated with this approach. Experts will share insights on recent breakthroughs and ongoing clinical trials.

Track 05

Adjuvant Technologies in Vaccine Development

This session will highlight the latest advancements in adjuvant technologies that enhance vaccine immunogenicity. Participants will discuss the mechanisms of action and the impact of adjuvants on vaccine efficacy.

Track 06

Bioprocessing Techniques for Vaccine Manufacturing

This track will cover the bioprocessing techniques essential for the large-scale production of vaccines. Experts will discuss optimization strategies, quality control measures, and regulatory considerations in vaccine manufacturing.

Track 07

Genetic Engineering in Vaccine Design

This session will explore the applications of genetic engineering in the design of novel vaccines. Researchers will present innovative approaches that leverage genetic modification to improve vaccine safety and effectiveness.

Track 08

Scalability Challenges in Vaccine Production

This track will address the challenges associated with scaling up vaccine production to meet global demand. Discussions will focus on technological innovations and strategic partnerships that can facilitate efficient vaccine distribution.

Track 09

Regulatory Frameworks for Vaccine Innovation

This session will provide an overview of the regulatory landscape governing vaccine development and approval. Experts will discuss the implications of regulatory policies on innovation and public health.

Track 10

Global Collaboration in Vaccine Research

This track will emphasize the importance of international collaboration in advancing vaccine research and development. Participants will share successful models of partnership that have led to significant breakthroughs in vaccine technology.

Track 11

Ethical Considerations in Vaccine Development

This session will explore the ethical implications surrounding vaccine research, including issues of equity, access, and informed consent. Experts will engage in discussions on how to navigate ethical dilemmas in the context of rapid vaccine innovation.